← Back
$CRGX All transactions

CARGO Therapeutics, Inc.

D

$ Value

Shares

25,000

Price

Filed

Aug 19

Insider

Name

Lubner David Charles

Title

CIK

0001572000

Roles

Director

Transaction Details

Transaction Date

2025-08-19

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 7, 2025, by and among CARGO Therapeutics, Inc. (the "Issuer"), Concentra Biosciences, LLC ("Parent") and Concentra Merger Sub VII, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). On August 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a "Share") for an offer price of (i) $4.379 per Share in cash (the "Cash Amount"), and (ii) one non-transferable contractual contingent value right (each, a "CVR"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the "CVR Agreement"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the "Offer Price"). [continues to Footnote 2] | [continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). As of immediately prior to and conditioned upon the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was canceled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger [continues to Footnote 3] | [continues from Footnote 2] and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was canceled for no consideration.

Filing Info

Accession No.

0001610717-25-000303

Form Type

4

Issuer CIK

0001966494

Lubner David Charles's History

Date Ticker Type Value
2025-08-19 CRGX D
2025-06-23 CBIO A $0
2025-06-18 CRGX A $0
2025-05-30 DYN A $0
2025-05-29 ACLX A $0
2025-05-22 VOR A $0

Other Insiders at CRGX (90d)

No other insider activity at this issuer in the last 90 days.